161 information-security "https:" "https:" "https:" "https:" positions at City of Hope
Sort by
Refine Your Search
-
, shaping the future of medicine through cutting-edge research. The Jianjun Chen Lab at City of Hope is looking for talented Postdoctoral Fellows to study cancer and stem cell biology. There are multiple
-
, shaping the future of medicine through cutting-edge research. A Postdoctoral Fellow position is available in the laboratory of Dr. Sangeeta Dhawan, at the Arthur Riggs Diabetes and Metabolism Research
-
Technician, Animal Care is responsible for the husbandry care of laboratory animals, including monitoring and reporting animal health status, providing feed and water, changing cages, environmental monitoring
-
-edge research. A Research Associate II position is available in the lab of Dr. Christine Brown of the T Cell Therapeutics Research Laboratories (TCTRL). This is a fast-paced lab involved in cutting-edge
-
-DMRI is a component of the Beckman Research Institute (BRI) at City of Hope. Our research depth in diabetes and cancer makes this institution unique, providing opportunities for scientific and clinical
-
from inception to implementation Create and execute project plans, timelines, and budgets Coordinate content and maintain SCT website content and ensure that it is routinely updated Establish routine
-
characterization of various gastrointestinal cancers (GI), including colorectal, pancreatic, gastric, esophageal, and hepatocellular cancers. Our group performs cutting-edge research in GI oncology, is very
-
relevant data and ensures both contracting and Revenue Integrity teams are supplied with finalized documentation. Enters, maintains and/or reviews financial data from finalized clinical trial agreements and
-
Postdoctoral Fellow. This is an excellent opportunity to join a well-established team and lead projects that culminate in publications in high-impact journals. Our research focuses on drug development
-
the endogenous immune system. We use this information to design solid-tumor targeted CAR effector cells with improved persistence and potency, as well as the ability to amplify the antitumor immune response. As a